Skip to main content
Equibles

HSBC HOLDINGS PLC

Position in PRLD — Prelude Therapeutics Inc

CIK 873630 LONDON, X0
Back to PRLD Full portfolio

Position in PRLD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$72,765
+$26,076 QoQ
Shares Held
13,652
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 75 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. PRLD ranks #119 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 676,247 $335,912,169
2 REGN
Regeneron Pharmaceuticals, Inc.
 382,028 $238,209,735
3 INCY
Incyte Corp
 1,307,743 $148,245,744
4 RPRX
Royalty Pharma plc
 1,224,925 $68,681,542
5 MRNA
Moderna, Inc.
 636,199 $44,553,014
6 ALNY
Alnylam Pharmaceuticals, Inc.
 115,279 $34,702,435
7 INSM
INSMED Inc
 279,961 $29,849,438
8 BMRN
Biomarin Pharmaceutical Inc
 307,543 $17,597,610

All Filings in PRLD

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $72,765 13,652
2026-03-31 $46,689 13,652
2025-12-31 $39,590 13,652
2025-09-30 $19,795 13,747
2025-06-30 $14,085 17,411
2025-03-31 $15,843 20,630
2024-12-31 $26,316 20,640
2024-09-30 $42,998 20,772
2024-06-30 $94,888 24,905
2024-03-31 $118,049 24,905
2023-12-31 $99,106 23,210
2023-09-30 $71,681 23,198